The oligonucleotide synthesis, modification and purification services market is estimated to be worth USD 5.8 billion in 2030, predicts Roots Analysis

The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs

Roots Analysis is pleased to announce the publication of its recent study, titled, “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030.”

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html

The report features an extensive study of the current scenario and future potential of the custom synthesis, modification and purification services market for oligonucleotides, which are intended for research, diagnostic, and therapeutic applications. The study includes in-depth analyses, highlighting the capabilities of service providers engaged in this domain. In addition to other elements, it includes:
A detailed review of the current status of the market with respect to oligonucleotide manufacturers focused on research and diagnostic, and therapeutic applications.
A competitiveness analysis of prominent oligonucleotide manufacturers, featuring insightful pictorial summaries and representations.
Elaborate profiles of key players that offer a diverse range of capabilities for custom synthesis, modification and purification of oligonucleotides.
An analysis of the various partnerships pertaining to oligonucleotide manufacturing, which have been established in the recent past.
An analysis of the various expansion initiatives undertaken by service providers engaged in this domain.
A detailed analysis of completed, ongoing and planned clinical research studies of various oligonucleotide-based drug products.
An estimate of the overall, annual capacity for manufacturing oligonucleotides based on data reported by industry stakeholders in the public domain.
An informed estimate of the annual clinical and commercial demand for oligonucleotides.
A discussion on affiliated trends, key drivers and challenges, under an elaborate SWOT framework.
A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing custom synthesis, modification and purification services for oligonucleotides.

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of Manufacturing
Custom Manufacturing
Large-scale Manufacturing
Type of Oligonucleotides Manufactured
Antisense Oligonucleotides
miRNAs
shRNAs
siRNAs
Other Oligonucleotides
Scale of Operation
Clinical
Commercial
Purpose of Production
In-house
Outsourced
Target Therapeutic Area
Autoimmune Disorders
Cardiovascular Disorders
Genetic Disorders
Infectious Diseases
Metabolic Disorders
Neuromuscular Disorders
Oncological Disorders
Ophthalmic Disorders
Other Therapeutic Areas
Size of manufacturer
Small
Mid-sized
Large
Key Geographical Region
North America
Europe
Asia-Pacific and Rest of the World
Transcripts of interviews held with the following senior level representatives of stakeholder companies
Joachim Bertram (Chief Scientific Officer and Managing Director, IBA Lifesciences)
Tobias Pohlmann (Founder and Managing Director, BianoScience)

Key companies covered in the report
Agilent Technologies
Ajinomoto Bio-Pharma Services
BioSpring
CordenPharma
Integrated DNA Technologies
Kaneka Eurogentec
LGC Biosearch Technologies
Microsynth
Nitto Denko Avecia
Sigma Aldrich
Thermo Fisher Scientific
Trilink Biotechnologies

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html

Other Recent Offerings
1. China Biopharmaceutical Contract Manufacturing Market, 2020-2030
2. Pharmaceutical Continuous Manufacturing Market, 2020-2030
3. Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030.

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.